Aytu Biopharma AYTU
NASDAQ AYTU
$2.07 -0.02 (-0.96%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aytu Biopharma (AYTU) Gains from Sales and Divestitures (2020 - 2022)

Updated

Aytu Biopharma (AYTU) reported Gains from Sales and Divestitures of $42,000 for fiscal Q1 2023 (quarter ended Sep 30, 2022).

Analysis

Aytu Biopharma (AYTU) Gains from Sales and Divestitures (2020 - 2022) Analysis & Trends

For FY2017 (ended Jun 30, 2017), Aytu Biopharma posted Gains from Sales and Divestitures of $428,374.

  • Five-year quarterly Gains from Sales and Divestitures spans a low of -$112,000 in fiscal Q1 2021 and a high of $100,000 in fiscal Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Aytu Biopharma 22.49 Mn -93.18 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 42,000.00
Mar 31, 2022 -6,000.00
Dec 31, 2021 100,000.00
Sep 30, 2020 -112,000.00
API Access

Aytu Biopharma Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=AYTU&period=max&api_key=YOUR_API_KEY